Washington, Sept 5 (ANI): Scientists have created a new class of anti-diabetic compound that is expected to better the treatment procedure for diabetes with minimal adverse side effects.
The joint study, by scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute, suggested that this new compound known as SR1664 could open up a new dimension in the anti-diabetic therapeutics.
"In this study, we demonstrate that we have discovered novel compounds that work effectively through a unique mechanism of action on a well-validated clinical target for diabetes," said researcher Patrick R. Griffin, professor and chair of the Department of Molecular Therapeutics at Scripps Florida.
"This unique mechanism of action appears to significantly limit side effects associated with marketed drugs," he added.
While S1664 likely will not be developed as a drug, it now serves as a molecular scaffolding for the creation of similar compounds with potential to treat diabetes.
The study was published in the September issue of Nature. (ANI)
null
|
|
Read More: Cancer
Comments:
